Oragenics, Inc.OGENNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-1.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -82.23% |
| Q2 2025 | 15.40% |
| Q1 2025 | 39.61% |
| Q4 2024 | -37.67% |
| Q3 2024 | -5.69% |
| Q2 2024 | 6.26% |
| Q1 2024 | 80.77% |
| Q4 2023 | -510.96% |
| Q3 2023 | 32.64% |
| Q2 2023 | -7.04% |
| Q1 2023 | -705.96% |
| Q4 2022 | 90.77% |
| Q3 2022 | -8.38% |
| Q2 2022 | 21.81% |
| Q1 2022 | -100.34% |
| Q4 2021 | 47.64% |
| Q3 2021 | -14.50% |
| Q2 2021 | 26.72% |
| Q1 2021 | -15.13% |
| Q4 2020 | -0.90% |
| Q3 2020 | 63.50% |
| Q2 2020 | -136.10% |
| Q1 2020 | -43.02% |
| Q4 2019 | 6.69% |
| Q3 2019 | 20.07% |
| Q2 2019 | -44.51% |
| Q1 2019 | -20.17% |
| Q4 2018 | -2.18% |
| Q3 2018 | -21.05% |
| Q2 2018 | -7.63% |
| Q1 2018 | -50.22% |
| Q4 2017 | 26.51% |
| Q3 2017 | -37.58% |
| Q2 2017 | 29.72% |
| Q1 2017 | 26.60% |
| Q4 2016 | -33.61% |
| Q3 2016 | -16.93% |
| Q2 2016 | 16.45% |
| Q1 2016 | 5.53% |
| Q4 2015 | -20.03% |